The PEBP2beta/CBF beta-SMMHC chimeric protein is localized both in the cell membrane and nuclear subfractions of leukemic cells carrying chromosomal inversion 16
Related Experiment Video
Updated: Oct 15, 2026

Genome-wide Analysis using ChIP to Identify Isoform-specific Gene Targets
Published on: July 7, 2010
1Department of Molecular Immunology, Institute of Development, Aging and Cancer, School of Medicine, Tohoku University, Sendai, Japan.
Abstract:
The chromosomal inversion (16)(p13q22), which is associated with the M4-eosinophilia subtype of human acute myeloid leukemia, causes the fusion of two distinct genes. The polypeptide encoded by the chimeric gene, PEBP2p/CBFp-SMMHC, retains the ability to interact with, and dominantly interfere with the function of proteins possessing the Runt homology domain. The Runt protein homologs constitute the DNA binding subunit of the PEBP2/CBF transcription factor. We examined the subcellular localization of PEBP2beta/CBFbeta-SMMHC, as well as that of Runt protein homologs in leukemic cells carrying inversion 16 by immunoblot analysis. A significant amount of the PEBPbeta/CBFbeta-SMMHC protein was recovered from the nuclear fraction along with the Runt protein homologs. Furthermore, some of both polypeptides was retained in the DNA pellet that represents the material remaining after extraction of nuclear fraction with high salt. These observations suggest that the so-called dominant interfering effect of PEBPbeta/CBFbeta-SMMHC on PEBP2/CBF occurs inside the nucleus. In addition, we could detect PEBP2beta/CBFbeta-SMMHC in the cytoplasmic membrane fraction as well. The function of this membrane-located PEBP2beta/CBFbeta-SMMHC, if any, appears to be unrelated to that of Runt protein homologs.
Insights
Chromosomal inversion (16)(p13q22) in acute myeloid leukemia creates a fusion protein that interferes with Runt protein function. This dominant interference occurs within the cell nucleus, impacting transcription factors.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- The chromosomal inversion (16)(p13q22) is a hallmark of the M4-eosinophilia subtype of acute myeloid leukemia (AML).
- This inversion leads to the formation of a chimeric gene encoding the PEBP2p/CBFp-SMMHC fusion protein.
- PEBP2p/CBFp-SMMHC interferes with the function of Runt homology domain proteins, which are crucial components of the PEBP2/CBF transcription factor.
Purpose of the Study:
- To investigate the subcellular localization of the PEBP2beta/CBFbeta-SMMHC fusion protein and Runt protein homologs in AML cells with inversion 16.
- To determine the site of dominant interference of PEBP2beta/CBFbeta-SMMHC on PEBP2/CBF function.
Main Methods:
- Immunoblot analysis of subcellular fractions from leukemic cells carrying inversion 16.
- Fractionation of nuclear components, including high-salt extraction to isolate DNA-bound proteins.
Main Results:
- Significant amounts of PEBP2beta/CBFbeta-SMMHC and Runt protein homologs were found in the nuclear fraction.
- Both polypeptides were detected in the DNA pellet, indicating interaction with DNA within the nucleus.
- PEBP2beta/CBFbeta-SMMHC was also found in the cytoplasmic membrane fraction, but its function there is unclear.
Conclusions:
- The dominant interfering effect of PEBP2beta/CBFbeta-SMMHC on PEBP2/CBF occurs within the cell nucleus.
- The presence of PEBP2beta/CBFbeta-SMMHC in the cytoplasmic membrane suggests potential non-canonical functions unrelated to Runt protein homologs.

